Kenty Wantri Anita

Kenty Wantri Anita

Auto-generated profile, based on publicly available information

Kenty Wantri Anita

Faculty of Medicine Brawijaya University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Journal of Pharmacy & Pharmacognosy Research
Verified
Journal Article
Open access
SPSofy Permana
Sofy Permana
LNLaili Nurzaidah
Laili Nurzaidah
EWEdwin Widodo
Edwin Widodo
KAKenty W. Anita
Kenty W. Anita
RNRaditya W. Nugraheni
Raditya W. Nugraheni
AEAgustina T. Endharti
Agustina T. Endharti
Context: Breast cancer expresses high levels of the estrogen receptor alpha (ER-α). Aims: To investigate the potential anticancer activity of nanoliposome Hedyotis corymbosa in breast cancer cells by specifically targeting the ER-α through a combination of in silico and in vitro studies. Methods: This study used molecular docking to analyze the interaction between ER-α and active compounds from H. corymbosa. In vitro studies, the H. corymbosa extract was converted into nanoliposomes. The nanoliposomes' characteristics were examined, combined with tamoxifen, and applied to breast cancer cell cultures. Viability, proliferation, and ER-α expression were assessed, and statistical analysis was performed (p<0.05). Results: The findings show that H. corymbosa compounds, especially rutin, inhibit ER-α binding and act as a substrate for P-glycoprotein. Extract H. corymbosa selectively decreases viability in breast cancer cells (T47D) compared to non-cancerous cells (NIH3T3). Combining extracts with tamoxifen at 10 mg/mL enhances treatment efficacy. The combined treatment is effective for up to 72 h, reducing T47D breast cancer cell proliferation. Nanoliposomes derived from extract exhibit favorable characteristics, including a spherical shape, uniform size distribution, and stability. Using these nanoliposomes at 100 μg/mL with tamoxifen significantly reduces ER-α expression (p<0.05) without affecting cell viability. Conclusions: Compounds from H. corymbosa, especially rutin, inhibit ER-α binding. H. corymbosa nanoliposomes are stable for drug delivery. Combining tamoxifen with nanoliposomes at 100 μg/mL reduces ER-alpha expression. This shows potential for breast cancer treatment, but validation through further research and clinical trials is necessary.


22 June 2025 in Meditory : The Journal of Medical Laboratory
Verified
Journal Article
Open access
PDF file
MPMade Dinda Pratiwi
Made Dinda Pratiwi
PAPrasetyo Adi
Prasetyo Adi
KAKenty Wantri Anita
Kenty Wantri Anita
Background: Diabetes mellitus (DM) type 2 is a metabolic disorder due to defects in insulin secretion. A microangiopathy complication of DM in the kidney can lead to renal enlargement. This augmentation in renal size can be attributed to several factors, including glomerular hypertrophy, tubular hypertrophy, and interstitial expansion. Retinoic acid, a vitamin A derivative, serves numerous cellular roles, including the induction of cell differentiation, the regulation of apoptosis, and exhibiting anti-inflammatory and antifibrotic properties.Objective: This study aims to evaluate the effect of vitamin A administration on the renal glomerular area in a rat model of type 2 diabetes mellitus. Methods: This study was experimental with five groups, including a negative control group, a positive diabetes mellitus group, and three groups of vitamin A treatment. The primary variable assessed was the glomerulus area across the different groups.Results: No significant decrease in glomerular area was observed in the vitamin A treatment group within the positive diabetes (ANOVA, p = 0.052).Conclusions: The findings of this study suggest that the administration of vitamin A does not significantly affect the reduction of renal glomerular area in rats with diabetes mellitus.